SLNO vs. TRML
Compare and contrast key facts about Soleno Therapeutics, Inc. (SLNO) and Tourmaline Bio Inc. (TRML).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SLNO or TRML.
Key characteristics
| SLNO | TRML | |
|---|---|---|
| YTD Return | 33.04% | -19.79% |
| 1Y Return | 1,087.36% | 61.91% |
| 3Y Return (Ann) | 55.65% | -30.64% |
| Sharpe Ratio | 2.02 | 0.71 |
| Daily Std Dev | 510.07% | 87.59% |
| Max Drawdown | -99.86% | -94.97% |
| Current Drawdown | -91.84% | -74.60% |
Fundamentals
| SLNO | TRML | |
|---|---|---|
| Market Cap | $2.06B | $495.90M |
| EPS | -$1.83 | -$1.92 |
| Total Revenue (TTM) | $3.45M | $2.28M |
| Gross Profit (TTM) | $1.42M | $880.00K |
| EBITDA (TTM) | -$67.34M | -$54.49M |
Correlation
The correlation between SLNO and TRML is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SLNO vs. TRML - Performance Comparison
In the year-to-date period, SLNO achieves a 33.04% return, which is significantly higher than TRML's -19.79% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SLNO vs. TRML - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and Tourmaline Bio Inc. (TRML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SLNO vs. TRML - Dividend Comparison
SLNO has not paid dividends to shareholders, while TRML's dividend yield for the trailing twelve months is around 71.99%.
| TTM | 2023 | |
|---|---|---|
SLNO Soleno Therapeutics, Inc. | 0.00% | 0.00% |
TRML Tourmaline Bio Inc. | 71.99% | 57.75% |
Drawdowns
SLNO vs. TRML - Drawdown Comparison
The maximum SLNO drawdown since its inception was -99.86%, which is greater than TRML's maximum drawdown of -94.97%. Use the drawdown chart below to compare losses from any high point for SLNO and TRML. For additional features, visit the drawdowns tool.
Volatility
SLNO vs. TRML - Volatility Comparison
The current volatility for Soleno Therapeutics, Inc. (SLNO) is 17.09%, while Tourmaline Bio Inc. (TRML) has a volatility of 24.57%. This indicates that SLNO experiences smaller price fluctuations and is considered to be less risky than TRML based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SLNO vs. TRML - Financials Comparison
This section allows you to compare key financial metrics between Soleno Therapeutics, Inc. and Tourmaline Bio Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities